Vimarsana
Biggest News Aggregation in the World

Page 41 - Drug Pricing Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Drug Pricing Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Drug Pricing Program Today - Breaking & Trending Today

Omnicell, Inc. (OMCL) CEO Randall Lipps on Q1 2022 Results - Earnings Call Transcript - Vimarsana News

Omnicell, Inc. (OMCL) CEO Randall Lipps on Q1 2022 Results - Earnings Call Transcript

Omnicell, Inc. (NASDAQ:NASDAQ:OMCL) Q1 2022 Earnings Conference Call April 28 2022 4:30 PM ET Company Participants Randall Lipps - Chairman, President, Chief Executive Officer Peter Kuipers...

Specialized cancer hospitals hike drug costs by up to 630%, study finds | Patrick Malone & Associates P.C. | DC Injury Lawyers - Vimarsana News

Specialized cancer hospitals hike drug costs by up to 630%, study finds | Patrick Malone & Associates P.C. | DC Injury Lawyers

While patients often seek treatment at big, fancy hospitals, in part because they are designated as National Cancer Institute centers, these institutions provide a sticker-shock...

Shusterman: Time to reform the 340B drug pricing program - Vimarsana News

Shusterman: Time to reform the 340B drug pricing program

My motto in office is "Common Sense Before Politics." I take this motto to heart. Every day, I work to ensure that politics does not get in...

Pharma and Healthcare Webinar with Polsinelli Law Firm - Vimarsana News

Pharma and Healthcare Webinar with Polsinelli Law Firm

340B Drug Pricing Program team intends to provide participants with much needed insight into the HIN number process and related brand drug manufacturer contract pharmacy restrictions.

Viewpoint: Cost-saving drug program needs transparency - Vimarsana News

Viewpoint: Cost-saving drug program needs transparency

Mass. regulators and lawmakers should bring greater oversight and transparency to 340B and modernize this outdated program.